Researchers introduced the PREVENT risk age equations to help determine risk of cardiovascular disease. (JAMA Cardiology) A ...

A post hoc analysis of the SUMMIT trial, published in JACC, reveals that baseline body mass index (BMI) and fat distribution ...

As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

Triggered Brand has agreed to pay $18,500 out of a $300,000 judgment after Attorney General William Tong sued the company in ...

Facebook posts reveal more GI side effects from semaglutide drugs like Ozempic than Mounjaro, offering new insights into ...

The updated standard replaces three previous guidelines and reflects the latest thinking on tackling obesity through the ...

People using weight loss medication have been told it's not a "quick fix" with many at risk of regaining their lost weight.

Health chiefs have raised concerns about patients regaining weight after stopping popular weight-loss drugs such as Wegovy ...

Patients ending obesity medication or finishing a weight management programme should be offered support to help keep the ...

Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price. The 'microdose' ...

Swiss generic drug manufacturer Sandoz plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard ...

People using weight loss medication have been warned it is not a "quick fix" with many at risk of regaining their lost weight ...